tiprankstipranks
Trending News
More News >
Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170)
:2170
Hong Kong Market

Suzhou Basecare Medical Corp. Ltd. Class H (2170) Financial Statements

Compare
0 Followers

Suzhou Basecare Medical Corp. Ltd. Class H Financial Overview

Suzhou Basecare Medical Corp. Ltd. Class H's market cap is currently HK$774.08M. The company's EPS TTM is HK$-0.939; its P/E ratio is ―; Suzhou Basecare Medical Corp. Ltd. Class H is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 299.11M¥ 207.98M¥ 140.90M¥ 107.30M¥ 81.11M
Gross Profit¥ 136.22M¥ 91.35M¥ 59.53M¥ 51.15M¥ 27.71M
Operating Income¥ -230.97M¥ -193.71M¥ -126.12M¥ -124.49M¥ -53.47M
EBITDA¥ -253.30M¥ -174.14M¥ -117.73M¥ -118.88M¥ -873.32M
Net Income¥ -237.03M¥ -191.69M¥ -123.16M¥ -143.65M¥ -877.05M
Balance Sheet
Cash & Short-Term Investments¥ 684.63M¥ 945.71M¥ 1.33B¥ 1.52B¥ 192.32M
Total Assets¥ 1.67B¥ 1.90B¥ 1.78B¥ 1.80B¥ 350.30M
Total Debt¥ 328.42M¥ 281.92M¥ 75.54M¥ 48.57M¥ 31.47M
Net Debt¥ -244.33M¥ -661.30M¥ -1.26B¥ -1.47B¥ -160.85M
Total Liabilities¥ 527.47M¥ 499.98M¥ 188.33M¥ 85.85M¥ 68.96M
Stockholders' Equity¥ 1.14B¥ 1.40B¥ 1.59B¥ 1.72B¥ 281.33M
Cash Flow
Free Cash Flow¥ -322.41M¥ -371.44M¥ -317.52M¥ -234.71M¥ -72.38M
Operating Cash Flow¥ -229.12M¥ -267.23M¥ -188.77M¥ -197.85M¥ -64.29M
Investing Cash Flow¥ -181.19M¥ -324.81M¥ -88.70M¥ -56.60M¥ 33.53M
Financing Cash Flow¥ 33.78M¥ 190.55M¥ 23.51M¥ 1.60B¥ 207.47M
Currency in CNY

Suzhou Basecare Medical Corp. Ltd. Class H Earnings and Revenue History

Suzhou Basecare Medical Corp. Ltd. Class H Debt to Assets

Suzhou Basecare Medical Corp. Ltd. Class H Cash Flow

Suzhou Basecare Medical Corp. Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis